Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1111/joim.13183

Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	125-128
Number of pages	4
Journal	Journal of Internal Medicine
Volume	289
Issue number	1
Early online date	20 Oct 2020
DOIs	https://doi.org/10.1111/joim.13183
Publication status	Published - 1 Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/joim.13183Licence: Unspecified

Cite this

@article{0d0b43b788fc4b31a2c98ad318c0214d,

title = "Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis",

keywords = "Proton pump inhibitor, COVID-19, Adverse clinical outcomes",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2021",

month = jan,

day = "1",

doi = "10.1111/joim.13183",

language = "English",

volume = "289",

pages = "125--128",

journal = "Journal of Internal Medicine",

issn = "0954-6820",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19

T2 - a meta‐analysis

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2021/1/1

Y1 - 2021/1/1

KW - Proton pump inhibitor

KW - COVID-19

KW - Adverse clinical outcomes

UR - http://www.scopus.com/inward/record.url?scp=85092734778&partnerID=8YFLogxK

U2 - 10.1111/joim.13183

DO - 10.1111/joim.13183

M3 - Letter

SN - 0954-6820

VL - 289

SP - 125

EP - 128

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

IS - 1

ER -

Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis

UN SDGs

Access to Document

Other files and links

Cite this